Cochlear Statistics
Total Valuation
Cochlear has a market cap or net worth of 8.38 billion. The enterprise value is 8.42 billion.
| Market Cap | 8.38B |
| Enterprise Value | 8.42B |
Important Dates
The last earnings date was Friday, February 13, 2026.
| Earnings Date | Feb 13, 2026 |
| Ex-Dividend Date | Sep 19, 2025 |
Share Statistics
| Current Share Class | n/a |
| Shares Outstanding | n/a |
| Shares Change (YoY) | -0.17% |
| Shares Change (QoQ) | -0.08% |
| Owned by Insiders (%) | 0.40% |
| Owned by Institutions (%) | 64.08% |
| Float | 65.14M |
Valuation Ratios
The trailing PE ratio is 36.38 and the forward PE ratio is 26.95.
| PE Ratio | 36.38 |
| Forward PE | 26.95 |
| PS Ratio | 5.37 |
| PB Ratio | 6.48 |
| P/TBV Ratio | 8.77 |
| P/FCF Ratio | 62.44 |
| P/OCF Ratio | 47.50 |
| PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 19.72, with an EV/FCF ratio of 62.73.
| EV / Earnings | 36.55 |
| EV / Sales | 5.03 |
| EV / EBITDA | 19.72 |
| EV / EBIT | 23.43 |
| EV / FCF | 62.73 |
Financial Position
The company has a current ratio of 2.46, with a Debt / Equity ratio of 0.12.
| Current Ratio | 2.46 |
| Quick Ratio | 1.34 |
| Debt / Equity | 0.12 |
| Debt / EBITDA | 0.41 |
| Debt / FCF | 1.20 |
| Interest Coverage | 43.40 |
Financial Efficiency
Return on equity (ROE) is 18.15% and return on invested capital (ROIC) is 19.15%.
| Return on Equity (ROE) | 18.15% |
| Return on Assets (ROA) | 11.28% |
| Return on Invested Capital (ROIC) | 19.15% |
| Return on Capital Employed (ROCE) | 22.53% |
| Weighted Average Cost of Capital (WACC) | 6.43% |
| Revenue Per Employee | 283,606 |
| Profits Per Employee | 41,877 |
| Employee Count | 5,500 |
| Asset Turnover | 0.84 |
| Inventory Turnover | 1.24 |
Taxes
In the past 12 months, Cochlear has paid 73.37 million in taxes.
| Income Tax | 73.37M |
| Effective Tax Rate | 24.16% |
Stock Price Statistics
The stock price has decreased by -22.50% in the last 52 weeks. The beta is 0.41, so Cochlear's price volatility has been lower than the market average.
| Beta (5Y) | 0.41 |
| 52-Week Price Change | -22.50% |
| 50-Day Moving Average | 82.38 |
| 200-Day Moving Average | 91.09 |
| Relative Strength Index (RSI) | 26.93 |
| Average Volume (20 Days) | 58,052 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, Cochlear had revenue of 1.56 billion and earned 230.32 million in profits. Earnings per share was 3.51.
| Revenue | 1.56B |
| Gross Profit | 1.14B |
| Operating Income | 335.78M |
| Pretax Income | 303.70M |
| Net Income | 230.32M |
| EBITDA | 374.87M |
| EBIT | 335.78M |
| Earnings Per Share (EPS) | 3.51 |
Balance Sheet
The company has 124.80 million in cash and 161.55 million in debt, with a net cash position of -36.75 million.
| Cash & Cash Equivalents | 124.80M |
| Total Debt | 161.55M |
| Net Cash | -36.75M |
| Net Cash Per Share | n/a |
| Equity (Book Value) | 1.29B |
| Book Value Per Share | 19.76 |
| Working Capital | 542.96M |
Cash Flow
In the last 12 months, operating cash flow was 176.43 million and capital expenditures -42.22 million, giving a free cash flow of 134.20 million.
| Operating Cash Flow | 176.43M |
| Capital Expenditures | -42.22M |
| Free Cash Flow | 134.20M |
| FCF Per Share | n/a |
Margins
Gross margin is 72.76%, with operating and profit margins of 21.53% and 14.77%.
| Gross Margin | 72.76% |
| Operating Margin | 21.53% |
| Pretax Margin | 19.47% |
| Profit Margin | 14.77% |
| EBITDA Margin | 24.03% |
| EBIT Margin | 21.53% |
| FCF Margin | 8.60% |
Dividends & Yields
This stock pays an annual dividend of 1.23, which amounts to a dividend yield of 1.90%.
| Dividend Per Share | 1.23 |
| Dividend Yield | 1.90% |
| Dividend Growth (YoY) | -0.52% |
| Years of Dividend Growth | n/a |
| Payout Ratio | 81.47% |
| Buyback Yield | 0.17% |
| Shareholder Yield | 2.07% |
| Earnings Yield | 2.75% |
| FCF Yield | 1.60% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
Cochlear has an Altman Z-Score of 15.24 and a Piotroski F-Score of 4.
| Altman Z-Score | 15.24 |
| Piotroski F-Score | 4 |